UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study

Blood, 2024-04, Vol.143 (17), p.1773-1781

2024

Volltextzugriff (PDF)

A novel scale-space approach for multinormality testing and the k-sample problem in the high dimension low sample size scenario

PloS one, 2019-01, Vol.14 (1), p.e0211044-e0211044

2019

Volltextzugriff (PDF)

Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors

Circulation (New York, N.Y.), 2022-10, Vol.146 (16), p.1225-1242

2022

Volltextzugriff (PDF)

High Levels of Complement Activating Enzyme MASP-2 Are Associated With the Risk of Future Incident Venous Thromboembolism

Arteriosclerosis, thrombosis, and vascular biology, 2022-09, Vol.42 (9), p.1186-1197

2022

Volltextzugriff (PDF)

High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism

Journal of thrombosis and haemostasis, 2023-07, Vol.21 (7), p.1849-1860

2023

Volltextzugriff (PDF)

Automatic nematode detection in cod fillets (Gadus morhua L.) by hyperspectral imaging

Journal of food engineering, 2012-08, Vol.111 (4), p.675-681

2012

Volltextzugriff (PDF)

Complement factors B, D, C3bBbP and risk of future venous thromboembolism

Clinical immunology (Orlando, Fla.), 2023-04, Vol.249, p.109278-109278, Article 109278

2023

Volltextzugriff (PDF)

Genetic variation of platelet glycoprotein VI and the risk of venous thromboembolism

Haematologica (Roma), 2020-07, Vol.105 (7), p.e358-e360

2020

Volltextzugriff (PDF)

Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism

Haematologica (Roma), 2016-09, Vol.101 (9), p.1046-1053

2016

Volltextzugriff (PDF)

Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism

Thrombosis research, 2018-09, Vol.169, p.50-56

2018

Volltextzugriff (PDF)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study

PloS one, 2016, Vol.11 (9), p.e0163242-e0163242

2016

Volltextzugriff (PDF)

Rewarming From Hypothermic Cardiac Arrest Applying Extracorporeal Life Support: A Systematic Review and Meta-Analysis

Frontiers in medicine, 2021-05, Vol.8, p.641633-641633

2021

Volltextzugriff (PDF)

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk

Research and practice in thrombosis and haemostasis, 2021-12, Vol.5 (8), p.e12640-n/a, Article e12640

2021

Volltextzugriff (PDF)

Long-term readmissions and complications in open and laparoscopic colorectal cancer (CRC) surgery: a propensity score matched analysis

Journal of the American College of Surgeons, 2014-10, Vol.219 (4), p.e146-e146

2014

Volltextzugriff (PDF)

The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study

TH open : companion journal to thrombosis and haemostasis, 2019-01, Vol.3 (1), p.e50-e57

2019

Volltextzugriff (PDF)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding

TH open : companion journal to thrombosis and haemostasis, 2019-01, Vol.3 (1), p.e77-e84

2019

Volltextzugriff (PDF)

Plasma lipopolysaccharide‐binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies

Journal of internal medicine, 2022-09, Vol.292 (3), p.523-535

2022

Volltextzugriff (PDF)

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study

TH open : companion journal to thrombosis and haemostasis, 2018-04, Vol.2 (2), p.e182-e189

2018

Volltextzugriff (PDF)

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study

TH open : companion journal to thrombosis and haemostasis, 2017-06, Vol.1 (1), p.e66-e72

2017

Volltextzugriff (PDF)

Abstract 110: C1 Esterase Inhibitor Functions As An Anticoagulant In Human And Murine Venous Thrombosis

Arteriosclerosis, thrombosis, and vascular biology, 2021-09, Vol.41 (Suppl_1)

2021

Volltextzugriff (PDF)

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort

TH open : companion journal to thrombosis and haemostasis, 2018-04, Vol.2 (2), p.e131-e138

2018

Volltextzugriff (PDF)

Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism

Blood, 2021-11, Vol.138 (21), p.2129-2137

2021

Volltextzugriff (PDF)

Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism

Journal of thrombosis and haemostasis, 2022

2022

Volltextzugriff (PDF)

Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism

Journal of thrombosis and haemostasis, 2022-07, Vol.20 (7), p.1618-1626

2022

Volltextzugriff (PDF)

Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism

Blood, 2021

2021

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(56)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study

A novel scale-space approach for multinormality testing and the k-sample problem in the high dimension low sample size scenario

Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors

High Levels of Complement Activating Enzyme MASP-2 Are Associated With the Risk of Future Incident Venous Thromboembolism

High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism

Automatic nematode detection in cod fillets (Gadus morhua L.) by hyperspectral imaging

Complement factors B, D, C3bBbP and risk of future venous thromboembolism

Genetic variation of platelet glycoprotein VI and the risk of venous thromboembolism

Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism

Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study

Rewarming From Hypothermic Cardiac Arrest Applying Extracorporeal Life Support: A Systematic Review and Meta-Analysis

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk

Long-term readmissions and complications in open and laparoscopic colorectal cancer (CRC) surgery: a propensity score matched analysis

The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding

Plasma lipopolysaccharide‐binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study

Abstract 110: C1 Esterase Inhibitor Functions As An Anticoagulant In Human And Murine Venous Thrombosis

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort

Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism

Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism

Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism

Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism

Suchergebnisse filtern